首页 | 本学科首页   官方微博 | 高级检索  
     


Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy
Authors:I. Brian Greenwell MD  Ashley D. Staton MD  Michael J. Lee MD  Jeffrey M. Switchenko PhD  MS  Debra F. Saxe PhD  Joseph J. Maly MD  Kristie A. Blum MD  Natalie S. Grover MD  Stephanie P. Mathews MD  Max J. Gordon MD  Alexey V. Danilov MD  PhD  Narendranath Epperla MD  MS  Timothy S. Fenske MD  Mehdi Hamadani MD  Steven I. Park MD  Christopher R. Flowers MD  MS  Jonathon B. Cohen MD  MS
Affiliation:1. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia;2. Division of Hematology/Oncology, The Ohio State University James Cancer Hospital, Columbus, Ohio;3. Division of Hematology/Oncology, University of North Carolina at Chapel Hill Lineberger Cancer Center, Chapel Hill, North Carolina;4. Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill Lineberger Cancer Center, Chapel Hill, North Carolina;5. Department of Medicine, OHSU Knight Cancer Institute, Portland, Oregon;6. Department of Hematology and Oncology, Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin;7. Levine Cancer Institute, Charlotte, North Carolina
Abstract:
Keywords:chemotherapy  complex karyotype  cytogenetics  mantle cell lymphoma (MCL)  prognostic markers
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号